EFDID: 313300EFD: View Filing

Issuer: Ashvattha Therapeutics, LLC (0001668528) - D

Accession: 0001144204-19-029203 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001668528
  • Entity Name:
    Ashvattha Therapeutics, LLC
  • Entity Type:
    Limited Liability Company
  • Jurisdiction:
    CALIFORNIA
  • Year of Inc:
    Within 5 years (2015)
  • Address:
    303 TWIN DOLPHIN DRIVE, SUITE 600
    REDWOOD CITY, CA 94065
  • Persons:
    Related Persons 5
    Jeffrey Cleland
    Executive Officer, Director 
    Executive Chairman, President and Manager of Company
    Sujatha Kannan
    Executive Officer, Director 
    Manager of Company
    Kannan Rangaramanujam
    Executive Officer, Director 
    Manager of Company
    Barbara Slusher
    Director
    Jay Zaveri
    Director 
    Manager of Company
EDGAR: Offering Information
  • Accession Date:
    05/31/2019
  • First Sale Date:
    05/17/2019
  • Offering Amount:
    $6,443,262
  • Amount Sold:
    $250,000
  • Amount Remaining:
    $6,193,262
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information

There were no Sales Compensation Recipient Information associated with this Accession Number.

EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Ashvattha Therapeutics, LLC/s/ Jeffrey ClelandJeffrey ClelandPresident2019-05-31